Egenskap
Swollen lymph nodes
Klinisk navn: Lymphadenopathy
Enlargement (swelling) of a lymph node.
Sammendrag
- Også kalt
- Lymph node hyperplasia
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Swollen lymph nodes, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test236 gener knyttet til Swollen lymph nodes
Endringer i disse genene forårsaker sjeldne tilstander der Swollen lymph nodes forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| CASP10caspase 10 | Alltid | I 2 tilstander |
| CASP8caspase 8 | Alltid | I 1 tilstand |
| CD70CD70 molecule | Alltid | I 1 tilstand |
| CTNNBL1catenin beta like 1 | Alltid | I 1 tilstand |
| CYBC1cytochrome b-245 chaperone 1 | Alltid | I 1 tilstand |
| HMOX1heme oxygenase 1 | Alltid | I 1 tilstand |
| IKZF2IKAROS family zinc finger 2 | Alltid | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Alltid | I 2 tilstander |
| IL6STinterleukin 6 cytokine family signal transducer | Alltid | I 1 tilstand |
| IRF8interferon regulatory factor 8 | Alltid | I 2 tilstander |
| ITKIL2 inducible T cell kinase | Alltid | I 1 tilstand |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Alltid | I 1 tilstand |
| LATlinker for activation of T cells | Alltid | I 1 tilstand |
| MAGT1magnesium transporter 1 | Alltid | I 1 tilstand |
| MCTS1MCTS1 re-initiation and release factor | Alltid | I 1 tilstand |
| NBNnibrin | Alltid | I 1 tilstand |
| NCKAP1LNCK associated protein 1 like | Alltid | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Alltid | I 3 tilstander |
| PLD4phospholipase D family member 4 | Alltid | I 1 tilstand |
| POLD3DNA polymerase delta 3, accessory subunit | Alltid | I 1 tilstand |
| PRKCDprotein kinase C delta | Alltid | I 1 tilstand |
| PSMG2proteasome assembly chaperone 2 | Alltid | I 1 tilstand |
| RASGRP1RAS guanyl releasing protein 1 | Alltid | I 1 tilstand |
| RC3H1ring finger and CCCH-type domains 1 | Alltid | I 1 tilstand |
| SHARPINSHANK associated RH domain interactor | Alltid | I 1 tilstand |
| SLC29A3solute carrier family 29 member 3 | Alltid | I 2 tilstander |
| STXBP2syntaxin binding protein 2 | Alltid | I 2 tilstander |
| TET2tet methylcytosine dioxygenase 2 | Alltid | I 4 tilstander |
| TPP2tripeptidyl peptidase 2 | Alltid | I 2 tilstander |
| TRACT cell receptor alpha constant | Alltid | I 1 tilstand |
| TRAF3TNF receptor associated factor 3 | Alltid | I 1 tilstand |
| UNGuracil DNA glycosylase | Alltid | I 1 tilstand |
| ZAP70zeta chain of T cell receptor associated protein kinase 70 | Alltid | I 2 tilstander |
| ADAadenosine deaminase | Svært ofte (80–99 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Svært ofte (80–99 %) | I 1 tilstand |
| BCL2BCL2 apoptosis regulator | Svært ofte (80–99 %) | I 1 tilstand |
| BCL6BCL6 transcription repressor | Svært ofte (80–99 %) | I 1 tilstand |
| CCND1cyclin D1 | Svært ofte (80–99 %) | I 2 tilstander |
| CD28CD28 molecule | Svært ofte (80–99 %) | I 2 tilstander |
| CHD7chromodomain helicase DNA binding protein 7 | Svært ofte (80–99 %) | I 1 tilstand |
Vis 196 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| CLCN7Cl-/H+ antiporter 7 | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 5 tilstander |
| DCLRE1CDNA cross-link repair 1C | Svært ofte (80–99 %) | I 2 tilstander |
| EIF2AK4eukaryotic translation initiation factor 2 alpha kinase 4 | Svært ofte (80–99 %) | I 1 tilstand |
| EWSR1EWS RNA binding protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 2 tilstander |
| FASLGFas ligand | Svært ofte (80–99 %) | I 1 tilstand |
| GINS1GINS complex subunit 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 4 tilstander |
| IGHimmunoglobulin heavy locus | Svært ofte (80–99 %) | I 3 tilstander |
| IL2RGinterleukin 2 receptor subunit gamma | Svært ofte (80–99 %) | I 1 tilstand |
| IL7Rinterleukin 7 receptor | Svært ofte (80–99 %) | I 3 tilstander |
| MVKmevalonate kinase | Svært ofte (80–99 %) | I 3 tilstander |
| NUDCD3NudC domain containing 3 | Svært ofte (80–99 %) | I 1 tilstand |
| OSTM1osteoclastogenesis associated transmembrane protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PSMB10proteasome 20S subunit beta 10 | Svært ofte (80–99 %) | I 1 tilstand |
| RAG1recombination activating 1 | Svært ofte (80–99 %) | I 2 tilstander |
| RAG2recombination activating 2 | Svært ofte (80–99 %) | I 2 tilstander |
| RIPK1receptor interacting serine/threonine kinase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Svært ofte (80–99 %) | I 1 tilstand |
| SNX10sorting nexin 10 | Svært ofte (80–99 %) | I 1 tilstand |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFRSF1BTNF receptor superfamily member 1B | Svært ofte (80–99 %) | I 2 tilstander |
| TNFSF11TNF superfamily member 11 | Svært ofte (80–99 %) | I 1 tilstand |
| WT1WT1 transcription factor | Svært ofte (80–99 %) | I 2 tilstander |
| ADA2adenosine deaminase 2 | Ofte (30–79 %) | I 1 tilstand |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Ofte (30–79 %) | I 1 tilstand |
| AICDAactivation induced cytidine deaminase | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| BRCA1BRCA1 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Ofte (30–79 %) | I 2 tilstander |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCBE1collagen and calcium binding EGF domains 1 | Ofte (30–79 %) | I 1 tilstand |
| CD27CD27 molecule | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Ofte (30–79 %) | I 1 tilstand |
| ELANEelastase, neutrophil expressed | Ofte (30–79 %) | I 1 tilstand |
| FAT4FAT atypical cadherin 4 | Ofte (30–79 %) | I 1 tilstand |
| FCHO1FCH and mu domain containing endocytic adaptor 1 | Ofte (30–79 %) | I 1 tilstand |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| IL6interleukin 6 | Ofte (30–79 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| ISG15ISG15 ubiquitin like modifier | Ofte (30–79 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Ofte (30–79 %) | I 1 tilstand |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Ofte (30–79 %) | I 1 tilstand |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Ofte (30–79 %) | I 1 tilstand |
| LMO1LIM domain only 1 | Ofte (30–79 %) | I 1 tilstand |
| MAP2K1mitogen-activated protein kinase kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| MIFmacrophage migration inhibitory factor | Ofte (30–79 %) | I 1 tilstand |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Ofte (30–79 %) | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ofte (30–79 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Ofte (30–79 %) | I 1 tilstand |
| OTULINOTU deubiquitinase with linear linkage specificity | Ofte (30–79 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Ofte (30–79 %) | I 1 tilstand |
| PALLDpalladin, cytoskeletal associated protein | Ofte (30–79 %) | I 1 tilstand |
| PHOX2Bpaired like homeobox 2B | Ofte (30–79 %) | I 1 tilstand |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Ofte (30–79 %) | I 2 tilstander |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| PRF1perforin 1 | Ofte (30–79 %) | I 2 tilstander |
| PSMB8proteasome 20S subunit beta 8 | Ofte (30–79 %) | I 1 tilstand |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| RAB27ARAB27A, member RAS oncogene family | Ofte (30–79 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Ofte (30–79 %) | I 1 tilstand |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Ofte (30–79 %) | I 1 tilstand |
| RNU4ATACRNA, U4atac small nuclear | Ofte (30–79 %) | I 2 tilstander |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Ofte (30–79 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Ofte (30–79 %) | I 2 tilstander |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstander |
| STAT1signal transducer and activator of transcription 1 | Ofte (30–79 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Ofte (30–79 %) | I 4 tilstander |
| STIM1stromal interaction molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| STX11syntaxin 11 | Ofte (30–79 %) | I 2 tilstander |
| SYKspleen associated tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| TLR8toll like receptor 8 | Ofte (30–79 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Ofte (30–79 %) | I 1 tilstand |
| TP53tumor protein p53 | Ofte (30–79 %) | I 1 tilstand |
| TSC1TSC complex subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| TSC2TSC complex subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| UNC13Dunc-13 homolog D | Ofte (30–79 %) | I 1 tilstand |
| WDR1WD repeat domain 1 | Ofte (30–79 %) | I 1 tilstand |
| YARS1tyrosyl-tRNA synthetase 1 | Ofte (30–79 %) | I 1 tilstand |
| ZNFX1zinc finger NFX1-type containing 1 | Ofte (30–79 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Noen ganger (5–29 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Noen ganger (5–29 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Noen ganger (5–29 %) | I 1 tilstand |
| BCORBCL6 corepressor | Noen ganger (5–29 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Noen ganger (5–29 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Noen ganger (5–29 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Noen ganger (5–29 %) | I 2 tilstander |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| CALRcalreticulin | Noen ganger (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Noen ganger (5–29 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Noen ganger (5–29 %) | I 2 tilstander |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Noen ganger (5–29 %) | I 1 tilstand |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Noen ganger (5–29 %) | I 1 tilstand |
| DLEC1DLEC1 cilia and flagella associated protein | Noen ganger (5–29 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Noen ganger (5–29 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Noen ganger (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Noen ganger (5–29 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Noen ganger (5–29 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Noen ganger (5–29 %) | I 1 tilstand |
| FOXN1forkhead box N1 | Noen ganger (5–29 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Noen ganger (5–29 %) | I 1 tilstand |
| FOXP3forkhead box P3 | Noen ganger (5–29 %) | I 2 tilstander |
| GATA2GATA binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| GPC3glypican 3 | Noen ganger (5–29 %) | I 1 tilstand |
| H19H19 imprinted maternally expressed transcript | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Noen ganger (5–29 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Noen ganger (5–29 %) | I 2 tilstander |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IL10interleukin 10 | Noen ganger (5–29 %) | I 2 tilstander |
| IL12Ainterleukin 12A | Noen ganger (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Noen ganger (5–29 %) | I 1 tilstand |
| IL2RBinterleukin 2 receptor subunit beta | Noen ganger (5–29 %) | I 2 tilstander |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Noen ganger (5–29 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Noen ganger (5–29 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Noen ganger (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Noen ganger (5–29 %) | I 2 tilstander |
| KLRC4killer cell lectin like receptor C4 | Noen ganger (5–29 %) | I 1 tilstand |
| LCATlecithin-cholesterol acyltransferase | Noen ganger (5–29 %) | I 1 tilstand |
| LIG4DNA ligase 4 | Noen ganger (5–29 %) | I 1 tilstand |
| LRBALPS responsive beige-like anchor protein | Noen ganger (5–29 %) | I 1 tilstand |
| LYSTlysosomal trafficking regulator | Noen ganger (5–29 %) | I 2 tilstander |
| MALT1MALT1 paracaspase | Noen ganger (5–29 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Noen ganger (5–29 %) | I 2 tilstander |
| MPLMPL proto-oncogene, thrombopoietin receptor | Noen ganger (5–29 %) | I 1 tilstand |
| MYD88MYD88 innate immune signal transduction adaptor | Noen ganger (5–29 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Noen ganger (5–29 %) | I 1 tilstand |
| POU6F2POU class 6 homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Noen ganger (5–29 %) | I 2 tilstander |
| PXKPX domain containing serine/threonine kinase like | Noen ganger (5–29 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Noen ganger (5–29 %) | I 1 tilstand |
| RESTRE1 silencing transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| RNF6ring finger protein 6 | Noen ganger (5–29 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Noen ganger (5–29 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| SDHCsuccinate dehydrogenase complex subunit C | Noen ganger (5–29 %) | I 1 tilstand |
| SOCS1suppressor of cytokine signaling 1 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Noen ganger (5–29 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TGFBR2transforming growth factor beta receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TRIM28tripartite motif containing 28 | Noen ganger (5–29 %) | I 1 tilstand |
| TRIP13thyroid hormone receptor interactor 13 | Noen ganger (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Noen ganger (5–29 %) | I 1 tilstand |
| WWOXWW domain containing oxidoreductase | Noen ganger (5–29 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Noen ganger (5–29 %) | I 1 tilstand |
| ASAH1N-acylsphingosine amidohydrolase 1 | Sjelden (1–4%) | I 1 tilstand |
| COL1A1collagen type I alpha 1 chain | Sjelden (1–4%) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Sjelden (1–4%) | I 1 tilstand |
| ACP5acid phosphatase 5, tartrate resistant | Ikke registrert | I 1 tilstand |
| ARPC1Bactin related protein 2/3 complex subunit 1B | Ikke registrert | I 1 tilstand |
| CARD9caspase recruitment domain family member 9 | Ikke registrert | I 1 tilstand |
| CD19CD19 molecule | Ikke registrert | I 1 tilstand |
| CYBAcytochrome b-245 alpha chain | Ikke registrert | I 1 tilstand |
| CYBBcytochrome b-245 beta chain | Ikke registrert | I 1 tilstand |
| ICOSinducible T cell costimulator | Ikke registrert | I 2 tilstander |
| MCM4minichromosome maintenance complex component 4 | Ikke registrert | I 1 tilstand |
| NCF1neutrophil cytosolic factor 1 | Ikke registrert | I 1 tilstand |
| NCF2neutrophil cytosolic factor 2 | Ikke registrert | I 1 tilstand |
| POMPproteasome maturation protein | Ikke registrert | I 1 tilstand |
| PSMB4proteasome 20S subunit beta 4 | Ikke registrert | I 1 tilstand |
| SH2D1ASH2 domain containing 1A | Ikke registrert | I 1 tilstand |
| SMPD1sphingomyelin phosphodiesterase 1 | Ikke registrert | I 1 tilstand |
| TNFRSF13BTNF receptor superfamily member 13B | Ikke registrert | I 1 tilstand |
| TNFRSF13CTNF receptor superfamily member 13C | Ikke registrert | I 1 tilstand |
| XIAPX-linked inhibitor of apoptosis | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
- Swollen lymph nodes in center of chest36 gener
- Follicular hyperplasia16 gener
- Generalized swelling of lymph nodes14 gener
- Swollen lymph nodes in the neck14 gener
- Chronic noninfectious lymphadenopathy9 gener
- Axillary lymphadenopathy6 gener
- Inguinal lymphadenopathy6 gener
- Hilar lymph node enlargement1 gen
- Paratracheal lymphadenopathy1 gen
- Submandibular lymph node enlargement1 gen
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker